Drug Type Small molecule drug |
Synonyms IACS-8300 |
Target |
Mechanism MAP3K12 inhibitors(Mitogen-activated protein kinase kinase kinase 12 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognition Disorders | Preclinical | US | - | |
Peripheral Nervous System Diseases | Preclinical | US | - |